1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with diclofenac in 6 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (diclofenac) | Trials (diclofenac) | Recent Studies (post-2010) (diclofenac) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 8,874 | 1,874 | 3,616 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | diclofenac (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.9 | |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.003 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.3376 | |
| Interleukin-8 | Homo sapiens (human) | 0.008 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0415 | |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | 0.5 | |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.012 | |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | 0.5 | |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | 0.5 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.4165 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.5 | |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | 0.5 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 1.6867 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.0502 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.5 | |
| P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alving, K; Lundberg, JM; Matran, R | 1 |
| Van Dijk, JP; Wilson, JH; Zijlstra, FJ | 1 |
| Duncker, HP; Heller, A; Koch, T; Neuhof, H; Schaible, R; van Ackern, K | 1 |
| de la Cruz, C; de Nicoläs, R; Egido, J; González, E; Herrero-Beaumont, G | 1 |
| Ben-Efraim, S; Bonta, IL; Heiligers, JP; Mózes, T; Saxena, PR; Tak, CJ; Zijlstra, FJ | 1 |
| Downing, SJ; Leese, HJ; Maguiness, SD; Tay, JI; Watson, A | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and diclofenac
| Article | Year |
|---|---|
Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diclofenac; Dinoprostone; Double-Blind Method; Female; Humans; Interleukin-1; Interleukin-6; Knee Joint; Leukotriene B4; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Osteoarthritis; Platelet Activating Factor; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 1994 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and diclofenac
| Article | Year |
|---|---|
The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig.
Topics: Allergens; Animals; Ascaris; Bronchi; Diclofenac; Platelet Activating Factor; Prostaglandin D2; Prostaglandins; Respiratory System; Swine; Vascular Resistance; Vasodilation | 1991 |
Increased platelet activating factor synthesis in experimental colitis after diclofenac and 5-amino-salicylic acid.
Topics: Aminosalicylic Acid; Animals; Colitis; Dextrans; Diclofenac; Diterpenes; Female; Ginkgolides; Lactones; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Prednisolone | 1993 |
Effects of stroma-free hemoglobin solutions on pulmonary vascular resistance and mediator release in the isolated perfused rabbit lung.
Topics: Animals; Azepines; Catalase; Cattle; Deferoxamine; Diclofenac; Female; Free Radical Scavengers; Hemoglobins; Histamine Release; Iron; Male; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Rabbits; Stimulation, Chemical; Thromboxane B2; Triazoles; Vascular Resistance; Vasoconstriction | 1994 |
Protective effect of diclofenac sodium against endotoxic shock in anaesthetized pigs.
Topics: Animals; Blood Cell Count; Blood Glucose; Diclofenac; Eicosanoids; Female; Hemodynamics; Hemoglobins; Lipopolysaccharides; Platelet Activating Factor; Regional Blood Flow; Shock, Septic; Swine; Tumor Necrosis Factor-alpha | 1993 |
Effect of inflammatory mediators on the physiology of the human Fallopian tube.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Diclofenac; Dose-Response Relationship, Drug; Electric Conductivity; Electrophysiology; Epithelial Cells; Fallopian Tubes; Female; Histamine; Humans; Ibuprofen; Indomethacin; Inflammation Mediators; Muscle Contraction; Muscle, Smooth; Naproxen; Pelvic Pain; Platelet Activating Factor | 2002 |